Sarah Will

1.1k citations

24 papers · 952 · h-index 15

Impact in

Endocrine and Autonomic Systems top 5%
- Regulation of Appetite and Obesity
Endocrinology, Diabetes and Metabolism top 5%
- Diabetes Treatment and Management

Papers in

Endocrine and Autonomic Systems 9
- Regulation of Appetite and Obesity 9
Endocrinology, Diabetes and Metabolism 8
- Diabetes Treatment and Management 8

Co-authors: Mylène Perreault (5 shared papers)James L. Trevaskis (8 shared papers)Stephanie N. Oldham (7 shared papers)Christopher J. Rhodes (6 shared papers)James F. Tobin (3 shared papers)Steven J. Kirincich (2 shared papers)Yanling Zhang (1 shared paper)Vipin Suri (1 shared paper)
Journals: Molecular Metabolism (5 papers)Diabetes Obesity and Metabolism (3 papers)Diabetes (3 papers)Pharmaceutics (2 papers)Endocrinology (2 papers)
Partner nations: United States United Kingdom Sweden

In The Last Decade

Sarah Will

24 papers receiving 907 citations

Peers

Countries citing papers authored by Sarah Will

Since Specialization

Citations

This map shows the geographic impact of Sarah Will's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Will with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Will more than expected).

Fields of papers citing papers by Sarah Will

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Will. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Will. The network helps show where Sarah Will may publish in the future.

Co-authors

The 25 scholars most cited alongside Sarah Will, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sarah Will Line = papers co-authored together Sarah Will links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Robust anti‐obesity and metabolic effects of a dual GLP ‐1/glucagon receptor peptide agonist in rodents and non‐human primates Diabetes Obesity and Metabolism ·Anish A. Konkar, David C. Hornigold, James L. Trevaskis, Robert N Jackson, Maria Fritsch Fredin, Rasmus Jansson‐Löfmark, Jacqui Naylor, Alessandra Rossi	2016	215
2	Molecular activation of PPARγ by angiotensin II type 1-receptor antagonists Vascular Pharmacology ·David V. Erbe, Katherine Gartrell, Yanling Zhang, Vipin Suri, Steven J. Kirincich, Sarah Will, Mylène Perreault, Suyue Wang	2006	124
3	Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent Proceedings of the National Academy of Sciences ·Dean R. Artis, Jack J. Lin, Chao Zhang, Weiru Wang, Upasana Mehra, Mylène Perreault, David V. Erbe, Heike I. Krupka	2008	120
4	Development of an orally delivered GLP-1 receptor agonist through peptide engineering and drug delivery to treat chronic disease Scientific Reports ·Sergei Pechenov, Jefferson D. Revell, Sarah Will, Jacqueline Naylor, Puneet Tyagi, Chandresh Patel, Lihuan Liang, Leo Tseng	2021	66
5	Disruption of G Protein-Coupled Receptor 39 Impairs Insulin Secretion in Vivo Endocrinology ·Frédéric Tremblay, Ann-Marie T. Richard, Sarah Will, Mylène Perreault, Ruth E. Gimeno +2 others	2009	61
6	Superior reductions in hepatic steatosis and fibrosis with co-administration of a glucagon-like peptide-1 receptor agonist and obeticholic acid in mice Molecular Metabolism ·Hani A. Jouihan, Sarah Will, Silvia Guionaud, Michelle L. Boland, Stephanie N. Oldham, Peter Ravn, Anthony J. Celeste, James L. Trevaskis	2017	55
7	Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction World Journal of Gastroenterology ·Michelle L. Boland, Stephanie N. Oldham, Brandon B. Boland, Sarah Will, Jean‐Martin Lapointe, Silvia Guionaud, Christopher J. Rhodes, James L. Trevaskis	2018	47
8	A GLP-1:CCK fusion peptide harnesses the synergistic effects on metabolism of CCK-1 and GLP-1 receptor agonism in mice Appetite ·David C. Hornigold, Emma Roth, VICTOR G. HOWARD, Sarah Will, Stephanie N. Oldham, Matthew P. Coghlan, Clémence Blouet, James L. Trevaskis	2018	34
9	Combined loss of GLP-1R and Y2R does not alter progression of high-fat diet-induced obesity or response to RYGB surgery in mice Molecular Metabolism ·Brandon B. Boland, Michael B. Mumphrey, Hao Zheng, R. Leigh Townsend, Benji M. Gill, Stephanie N. Oldham, Sarah Will, Christopher D. Morrison	2019	34
10	Hepatic glucagon action: beyond glucose mobilization Physiological Reviews ·Sarina Kajani, Rhianna Che Laker, Ekaterina L. Ratkova, Sarah Will, Christopher J. Rhodes	2024	32
11	Peptide-YY3-36/glucagon-like peptide-1 combination treatment of obese diabetic mice improves insulin sensitivity associated with recovered pancreatic β-cell function and synergistic activation of discrete hypothalamic and brainstem neuronal circuitries Molecular Metabolism ·Brandon B. Boland, Rhianna Che Laker, S. O'Brien, Sadichha Sitaula, Isabelle Sermadiras, Jens Christian Froslev Nielsen, Pernille Barkholt, Urmas Roostalu	2021	26
12	Activation of TrkB with TAM-163 Results in Opposite Effects on Body Weight in Rodents and Non-Human Primates PLoS ONE ·Mylène Perreault, Sarah Will, Tiffany Gareski, David Kubasiak, Kimberly Marquette, Yulia Vugmeyster, Thaddeus J. Unger, Juli E. Jones	2013	23
13	Specific loss of GIPR signaling in GABAergic neurons enhances GLP-1R agonist-induced body weight loss Molecular Metabolism ·Jordan Wean, Allison Ho Kowalsky, Rhianna Che Laker, Sarah Will, Daniel J. Drucker, Christopher J. Rhodes, Randy J. Seeley	2024	18
14	Prodrug delivery of novel PTP1B inhibitors to enhance insulin signalling Diabetes Obesity and Metabolism ·D.V. Erbe, Lori D. Klaman, Zhao‐Kui Wan, Steven J. Kirincich, Sarah Will, Xin Xu, Leslie Kung, S. Wang	2009	17
15	Loss of Coiled-Coil Domain Containing 80 Negatively Modulates Glucose Homeostasis in Diet-Induced Obese Mice Endocrinology ·Frédéric Tremblay, Christine Huard, Jessie Dow, Tiffany Gareski, Sarah Will, Ann-Marie T. Richard, Steven A. Bailey, Karrie A. Brenneman	2012	17
16	Behavioural and neurochemical mechanisms underpinning the feeding-suppressive effect of GLP-1/CCK combinatorial therapy Molecular Metabolism ·Emma Roth, Simon Benoit, Baptiste Quentin, Brian Lam, Sarah Will, Marcella K.L. Ma, Nick Heeley, Tamana Darwish	2020	13
17	Gut check on diabesity: leveraging gut mechanisms for the treatment of type 2 diabetes and obesity Current Opinion in Pharmacology ·Sarah Will, David C. Hornigold, Matthew P. Coghlan, Malcolm Mesquita, James L. Trevaskis, Jacqueline Naylor +1 other	2017	11
18	Modulation of nutrient sensing nuclear hormone receptors promotes weight loss through appetite suppression in mice Diabetes Obesity and Metabolism ·Mylène Perreault, Sarah Will, Darrell Panza, Tiffany Gareski, David Kubasiak, Mary Jalenak, Katherine Gartrell, S. Wang	2009	10
19	Injectable Biodegradable Silica Depot: Two Months of Sustained Release of the Blood Glucose Lowering Peptide, Pramlintide Pharmaceutics ·Puneet Tyagi, Mika Koskinen, Jari H. Mikkola, Sanjay Sarkhel, Lasse Leino, Asha Seth, Shimona Madalli, Sarah Will	2022	10
20	GLP-1R/GCGR dual agonism dissipates hepatic steatosis to restore insulin sensitivity and rescue pancreatic β-cell function in obese male mice Nature Communications ·Rhianna Che Laker, Shaun Egolf, Sarah Will, Louise Lantier, Owen P. McGuinness, Charles L. Brown, Nicholas V. Bhagroo, Stephanie N. Oldham	2025	8

About Sarah Will

Sarah Will is a scholar working on Endocrine and Autonomic Systems, Endocrinology, Diabetes and Metabolism, Pharmaceutical Science, Epidemiology and Surgery, having authored 24 papers that have together received 952 indexed citations. Recurring topics across this work include Regulation of Appetite and Obesity (9 papers), Diabetes Treatment and Management (8 papers), Liver Disease Diagnosis and Treatment (3 papers), Pancreatic function and diabetes (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Advanced Drug Delivery Systems (3 papers), Drug Solubulity and Delivery Systems (2 papers) and Bariatric Surgery and Outcomes (2 papers). The work is most often cited by research in Endocrine and Autonomic Systems (120 citations), Endocrinology, Diabetes and Metabolism (241 citations), Pharmaceutical Science (52 citations), Epidemiology (141 citations) and Pharmacology (61 citations). Sarah Will has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include Mylène Perreault, James L. Trevaskis, Stephanie N. Oldham, Christopher J. Rhodes, James F. Tobin, Steven J. Kirincich, Yanling Zhang, Vipin Suri, Suyue Wang and David V. Erbe. Their work appears in journals such as Molecular Metabolism, Diabetes Obesity and Metabolism, Diabetes, Pharmaceutics and Endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Sarah Will

Impact in

Papers in i

In The Last Decade

Sarah Will

Peers

Countries citing papers authored by Sarah Will

Fields of papers citing papers by Sarah Will

All Works

About Sarah Will

Explore authors with similar magnitude of impact

Papers in